Overview

Elobixibat Colonic Motor Function Study

Status:
Withdrawn
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This is a randomized trial of 36 otherwise healthy patients with chronic idiopathic constipation. The purpose of the study is to compare the effects of daily single-dose oral elobixibat and placebo for 7 days on colonic motor effects.
Phase:
Phase 2
Details
Lead Sponsor:
Ferring Pharmaceuticals